← Leaderboards
Rebecca L Skalsky
Oregon Health & Science University
$5,221,945
Attributed
$5,221,945
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $806.7K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,221,945 · 7
By mechanism
R01$3,232,869 · 2
R21$1,072,649 · 3
R00$717,120 · 1
K99$199,307 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jay A Nelson$38,488,581
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInfectionVirusGene ExpressionViralIn VitroMalignant NeoplasmsHuman Herpesvirus 4Virus DiseasesMicrornasPathway InteractionsEpstein-Barr Virus InfectionsViral ProteinsPathogenesisMolecularProgramsIn VivoB-LymphocytesAcquired Immunodeficiency SyndromeTranscriptomeLinkMediatingRegulationLife Cycle Stages
Grant awards (17)
KSHV Manipulates Host Iron Metabolism and Ferroptotic Cell Death Pathways, Creating Novel Vulnerability Points for Therapeutic Intervention.$352,274
R01 · FY2025 · CA · contact PI
Impact of SARS CoV2 on Human Herpesvirus Co-Infections$234,000
R21 · FY2025 · HL · contact PI
KSHV Manipulates Host Iron Metabolism and Ferroptotic Cell Death Pathways, Creating Novel Vulnerability Points for Therapeutic Intervention.$352,275
R01 · FY2024 · CA · contact PI
Characterizing single cell states of activated and transformed B cells in rhesus macaque models$197,676
R21 · FY2024 · AI · contact PI
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation$570,528
R01 · FY2023 · AI · contact PI
Characterizing single cell states of activated and transformed B cells in rhesus macaque models$236,176
R21 · FY2023 · AI · contact PI
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation$714,774
R01 · FY2022 · AI · contact PI
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation$401,661
R01 · FY2021 · AI · contact PI
Regulation of host miRNA activity by Epstein-Barr virus BHRF1$176,000
R21 · FY2021 · AI · contact PI
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation$426,264
R01 · FY2020 · AI · contact PI
Regulation of host miRNA activity by Epstein-Barr virus BHRF1$228,797
R21 · FY2020 · AI · contact PI
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation$415,093
R01 · FY2019 · AI · contact PI
The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis$219,120
R00 · FY2018 · CA · contact PI
The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis$249,000
R00 · FY2017 · CA · contact PI
The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis$249,000
R00 · FY2016 · CA · contact PI
The role of viral and cellular miRNAs in B-cell lymphomagenesis$99,351
K99 · FY2015 · CA · contact PI
The role of viral and cellular miRNAs in B-cell lymphomagenesis$99,956
K99 · FY2014 · CA · contact PI